NEUROONE MEDICAL TECHNOLOGIES Corp (NMTC) stock
NMTCNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends September 30
Financials through Q3 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 13, 2026Score 11/3079% below fair value
$0.71−0.04 (-5.15%)
Close on Nov 17, 2026Market cap $6.43MP/E –Yield –
Neuroone Medical Technologies price to sales ratio
The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.
Neuroone Medical Technologies's price to sales ratio was 0.7× on Nov 11, 2026, against 3.8× a year earlier. Over the last 5 years it ranged from 0.7× to 274.0×, with a median of 10.0×.
Price to Sales Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Nov 11, 2026 | 0.7× | −3.4 |
| 2025 | Dec 31, 2025 | 4.2× | −3.2 |
| 2024 | Dec 31, 2024 | 7.4× | −12.0 |
| 2023 | Dec 29, 2023 | 19.4× | −94.3 |
| 2022 | Dec 30, 2022 | 113.7× | −17.1 |
| 2021 | Dec 31, 2021 | 130.8× | – |
See a number that looks wrong?